Study Shows African American Men with Advanced Prostate Cancer Treated with PROVENGE® (sipuleucel-T) Live Longer than Caucasian Men

Autor: Dendreon Pharmaceuticals
Zdroj: Business Wire (English). 03/12/2020.
Abstrakt: Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today announced findings from a sub-analysis of data from its PROCEED registry comparing overall survival (OS) in African American (AA) and Caucasian (CAU) men with metastatic castrate-resistant prostate cancer (mCRPC) who were treated with PROVENGE® (sipuleucel-T) in a real-world treatment setting. [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje